Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Completed · Phase 3 · Has a placebo group
Conditions studied: Small Cell Lung Carcinoma
In brief
The purpose of the study is to determine whether the addition of Ipilimumab to Etoposide and Platinum therapy will extend the lives of patients with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) more than Etoposide and Platinum therapy alone.
Key facts
- Study ID
- NCT01450761
- Run by
- Bristol-Myers Squibb
- People needed
- 1351
- Starts
- 2011-12-13
- Expected to finish
- 2017-05-17
- Last updated by the study team
- 2020-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)
- Eastern Cooperative Oncology Group (ECOG) of 0 or 1
You may not qualify if…
- Prior systemic therapy for lung cancer
- Symptomatic Central Nervous System (CNS) metastases
- History of autoimmune disease
Where it is running
- Sutter Medical Center — Auburn, California, United States
- UCSD Moores Cancer Center — La Jolla, California, United States
- University Of Colorado Cancer Center — Aurora, Colorado, United States
- Florida Cancer Specialists S. — Fort Myers, Florida, United States
- Cancer Specialists, LLC — Jacksonville, Florida, United States
- Lake City Cancer Care — Lake City, Florida, United States
- Florida Cancer Specialists — St. Petersburg, Florida, United States
- Medical Oncology, LLC — Augusta, Georgia, United States
- Quincy Medical Group — Quincy, Illinois, United States
- Presence Medical Group Hematology Oncology — Skokie, Illinois, United States
- SIU School Of Medicine — Springfield, Illinois, United States
- St. Francis Medical Group Oncology And Hematology Specialist — Indianapolis, Indiana, United States
- Cancer Center Of Kansas — Wichita, Kansas, United States
- Ashland Bellefonte Cancer Center — Ashland, Kentucky, United States
- University Of Kentucky — Lexington, Kentucky, United States
- Montgomery Cancer Center — Mount Sterling, Kentucky, United States
- St Joseph Mercy Hospital — Ypsilanti, Michigan, United States
- St. Luke'S Cancer Institute — Kansas City, Missouri, United States
- Southeast Nebraska Hematology & Oncology Consultants, P.C. — Lincoln, Nebraska, United States
- Regional Cancer Care Associates, LLC/Cherry Hill Division — Cherry Hill, New Jersey, United States
- Memorial Sloan Kettering Nassau — New York, New York, United States
- Gabrail Cancer Center — Canton, Ohio, United States
- Oncology Hematology Care, Incorporated — Cincinnati, Ohio, United States
- University Hospitals — Cleveland, Ohio, United States
- Genesis Cancer Center — Hot Springs, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.